The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies

The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies

Abstract Ovarian cancer is the leading cause of gynecologic cancer death in the world, and its prevention and early diagnosis remain the key to its treatment, especially for high‐grade serous carcinoma (HGSC). Accumulating epidemiological and molecular evidence has shown that HGSC originates from fa...

Bibliografske podrobnosti
Main Authors:	Satoru Kyo, Noriyoshi Ishikawa, Kohei Nakamura, Kentaro Nakayama
Format:	Article
Jezik:	English
Izdano:	Wiley 2020-01-01
Serija:	Cancer Medicine
Teme:	BRCA mutations cancer biology cancer genetics gynecological oncology
Online dostop:	https://doi.org/10.1002/cam4.2725

Podobne knjige/članki

Ovarian cancer: the Fallopian tube as the site of origin and opportunities for prevention
od: Sophia HL George, PhD, et al.
Izdano: (2016-05-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
od: Patricia Martini Diniz, et al.
Izdano: (2011-01-01)

Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
od: Natalie Herold, et al.
Izdano: (2023-07-01)

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
od: Karin Hellner, et al.
Izdano: (2016-08-01)

Gynecologic and breast cancers with hereditary cancer predisposition syndromes
od: Courtney F. Connelly, et al.
Izdano: (2024-11-01)

The Prognostic Relevance of Poly (ADP-Ribose) Polymerase Expression in Ovarian Cancer Tissue of Wild Type and BRCA-Mutation Carrier Patients
od: Szabolcs Molnár, et al.
Izdano: (2021-01-01)

High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy
od: Domenica Lorusso, et al.
Izdano: (2013-01-01)

Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women
od: Naela Agha, et al.
Izdano: (2022-01-01)

The discrepancy of somatic BRCA1/2 pathogenic variants from two different platforms in epithelial ovarian, fallopian tube, and peritoneal cancer
od: Ji Hyun Kim, et al.
Izdano: (2024-10-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
od: Ashour M, et al.
Izdano: (2019-07-01)

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
od: M.G. Davey, et al.
Izdano: (2021-04-01)

Case Report: Frontoparietal Metastasis From a Primary Fallopian Tube Carcinoma
od: Anthony I. Jang, et al.
Izdano: (2021-02-01)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
od: Tarinee Manchana, et al.
Izdano: (2020-08-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
od: Yomali Ferreyra, et al.
Izdano: (2023-08-01)

Lymphadenectomy in Primary Fallopian Tube Cancer is Associated with Improved Survival
od: Yao Xiao, et al.
Izdano: (2022-06-01)

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
od: Tomasz Kluz, et al.
Izdano: (2018-02-01)

Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
od: V.F. Esteves, et al.
Izdano: (2009-05-01)

A systematic review on the association between ovarian and prostate cancer with <I>BRCA1</I> and <I>BRCA2</I> gene
od: Sarpparajan Chitra Veena, et al.
Izdano: (2023-01-01)

CLINICAL AND MORPHOLOGICAL FEATURES OF HEREDITARY OVARIAN CANCER
od: K. B. Kotiv, et al.
Izdano: (2017-12-01)

Defining fallopian tube‐derived miRNA cancer signatures
od: Selam B. Dejene, et al.
Izdano: (2019-11-01)

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer
od: F Schoumacher, et al.
Izdano: (2001-04-01)

Hereditary breast and ovarian cancer – University Hospital of Split experiences
od: Branka Petrić-Miše, et al.
Izdano: (2023-01-01)

Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples – single institution study
od: Artur Kowalik, et al.
Izdano: (2019-02-01)

Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis
od: Basilio Pecorino, et al.
Izdano: (2022-11-01)

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System
od: Caroline de Oliveira Ferreira, et al.
Izdano: (2024-04-01)

Somatic BRCA Mutation in High Grade Epithelial Ovarian Cancer Patients
od: Tarinee Manchana, et al.
Izdano: (2019-01-01)

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
od: Narod Steven
Izdano: (2004-02-01)

Angelina′s choice
od: Nishu Singh Goel
Izdano: (2013-01-01)

The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview
od: Sandra Sarnacka, et al.
Izdano: (2024-05-01)

BRCA1 4153delA founder mutation in Russian ovarian cancer patients
od: Krylova Nadezhda, et al.
Izdano: (2006-09-01)

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
od: Crisle Vignol Dillenburg, et al.
Izdano: (2012-01-01)

Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
od: Tullio Golia D'Augè, et al.
Izdano: (2023-08-01)

Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
od: Jiayu Wang, et al.
Izdano: (2019-05-01)

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
od: Dorra Ben Ayed-Guerfali, et al.
Izdano: (2021-03-01)

Prediction of BRCA gene mutation status in epithelial ovarian cancer by radiomics models based on 2D and 3D CT images
od: Liu Mingzhu, et al.
Izdano: (2021-11-01)

Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
od: Deborah Porto Cotrim, et al.
Izdano: (2019-01-01)

Diagnosis and treatment of ovarian cancer in the light of modern molecular genetic achievements
od: E. M. Kagirova, et al.
Izdano: (2023-11-01)

A case report of long-term successful use of maintenance therapy with PARP inhibitors in the primary treatment of advanced BRCA-associated ovarian cancer
od: О. N. Churuksaeva, et al.
Izdano: (2023-09-01)

Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors
od: M. E. Esenova, et al.
Izdano: (2021-11-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
od: Pankaja Umarane, et al.
Izdano: (2023-03-01)